Skip to main content
Clinical Trials/NCT02394899
NCT02394899
Completed
N/A

Integrating a Parenting Intervention With Routine Care to Improve Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease

The University of The West Indies1 site in 1 country64 target enrollmentOctober 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Sickle Cell Disease
Sponsor
The University of The West Indies
Enrollment
64
Locations
1
Primary Endpoint
Infant's development quotient (Griffiths Developmental Scale)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

There are all significant risk factors for poor early cognitive development and, as such, neurocognitive deficits have been demonstrated in pre-school children with sickle cell disease (SCD). This project assesses the efficacy of using an evidence-based early stimulation program, combined with components to help parents cope with stress, delivered during six routine monthly clinic visits to parents of children with sickle cell disease. It is hoped that this innovation will improve parental psychological outcomes, as well as child developmental outcomes.

Detailed Description

Children with sickle cell disease (SCD) are at risk of various complications, many of which arise suddenly and call on the problem solving skills of their parents. They are also at risk of neurocognitive delays; these may become evident during the pre-school years. Previous research by this group has demonstrated improved developmental outcomes after parental interventions incorporating play techniques in high risk and healthy pre-school children. The aim of the study is to determine usefulness in children with SCD of similar developmental interventions augmented by lessons in problem solving. The study is a randomized controlled trial. Parents of all infants with Hb SS (homozygous sickle cell disease) or Sβ0 -thalassemia disease identified by newborn screening during the initial year of the study will be invited to participate. They will be randomized to intervention or control. Parental stress, infant's development and hemoglobin levels will be measured at recruitment and again after six months. The intervention will occur during monthly Penadur (intramuscular Benzathine Penicillin) visits and will include supervised play with their children using an inexpensive toy and participation in solving a problem which may arise as they parent their child with SCD. At the end of the study, all control dyads will also be given the toys used in the intervention. All parents will be given the results of their children's developmental assessments and appropriate referrals made if deficits are identified. The study is minimal risk. Every effort will be made to maintain patient confidentiality. Respect for, and the maximum protection of the best interests of the research subjects will be maintained.

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
September 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Infant has sickle cell disease: SS or Sβ0 thalassemia
  • Attending Sickle Cell Unit, Jamaica for routine care

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Infant's development quotient (Griffiths Developmental Scale)

Time Frame: 6 months

Griffiths Developmental Scale

Parental stress, depression and coping (Pediatric Inventory for Parents; CES-D; Coping Health Inventory for parents)

Time Frame: 6 months

Questionnaires to assess: Pediatric Inventory for Parents; CES-D; Coping Health Inventory for parents

Parental problem solving skills (Social Problem Solving Inventory)

Time Frame: 6 months

Using Social Problem Solving Inventory: Questionnaires

Study Sites (1)

Loading locations...

Similar Trials